Adient (ADNT)
(Delayed Data from NYSE)
$22.16 USD
+0.37 (1.70%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $22.16 0.00 (0.00%) 6:12 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.16 USD
+0.37 (1.70%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $22.16 0.00 (0.00%) 6:12 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
Zacks News
Adient (ADNT) Incurs Q1 Loss, Surpasses Sales Estimates
by Zacks Equity Research
Adient (ADNT) incurs a loss in fiscal Q1 due to downsized EBITDA across segments brought about by the global market headwinds.
Adient (ADNT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -575% and 2.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Wabash National (WNC) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Wabash (WNC) delivered earnings and revenue surprises of -41.67% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 2.94% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
Auto Stock Roundup: WPRT & ADNT Quarterly Results, DDAIF Twin Deals & More
by Rimmi Singhi
While Westport (WPRT) and Adient (ADNT) deliver quarterly losses, Daimler (DDAIF) collaborates with Total Energies and Visa.
Adient's (ADNT) Q4 Loss Narrower Than Expected, Sales Miss
by Zacks Equity Research
Adient (ADNT) expects fiscal 2022 revenues of $14.8 billion, higher than $13.7 billion recorded in fiscal 2021.
Key Factors to Note Ahead of Hyliion's (HYLN) Q3 Earnings
by Zacks Equity Research
Rising R&D and SG&A expenses are likely to have dented Hyliion's (HYLN) Q3 performance.
Lear's (LEA) Q3 Earnings Miss Estimates, 2021 View Tepid
by Zacks Equity Research
Lear (LEA) forecasts full-year 2021 sales in the band of $18.8-$19.2 billion, down from the previous guided range of $20.3-$21.1 billion.
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Factors to Note Ahead of Magna's (MGA) Q3 Earnings
by Zacks Equity Research
Declining revenues across all segments and rising costs are likely to have dented Magna's (MGA) Q3 performance.
Oshkosh (OSK) Beats Q4 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Oshkosh (OSK) delivers a comprehensive fiscal Q4 beat and announces a 12% dividend hike.
Allison (ALSN) Q3 Earnings Match Estimates, Sales Beat
by Zacks Equity Research
Amid persistent supply chain disruptions, Allison (ALSN) trims its 2021 guidance. It now projects net sales in the band of $2,325-$2,400 million versus the prior estimate of $2,325-$2,475 million.
Gentex (GNTX) Lags Q3 Earnings & Sales Estimates, Revises 2H'21 View
by Zacks Equity Research
Gentex (GNTX) envisions net sales in the band of $770-$840 million for second-half 2021, lower than the previous outlook of $970 million-$1.07 billion.
New Strong Sell Stocks for October 11th
by Zacks Equity Research
ADNT, MOMO, LEA, PLUG and TEN have been added to the Zacks Rank #5 (Strong Sell) List on October 11, 2021.
Adient (ADNT) Down 2.5% Since Q3 Loss, Slashes FY21 View
by Zacks Equity Research
Adient (ADNT) projects fiscal 2021 revenues within $14.3-$14.5 billion, lower than the prior outlook of $14.6-$15 billion.
Magna (MGA) Q2 Earnings & Sales Miss Mark, Trims '21 View
by Zacks Equity Research
Magna (MGA) downwardly revises 2021 outlook amid chip crunch. It now expects revenues in the band of $38-$39.5 billion, down from the previous view of $40.2-$41.8 billion.
Allison (ALSN) Down 2.8% Since Q2 Earnings & Sales Beat
by Zacks Equity Research
Allison Transmission (ALSN) projects adjusted free cash flow within $415-$475 million for 2021.
LEAR (LEA) Q2 Earnings Beat, Sales Miss Estimates, '21 View Down
by Zacks Equity Research
For 2021, Lear (LEA) projects net sales of $19.7-$20.5 billion, lower than the earlier forecast of $20.3-$21.1 billion.
Meritor (MTOR) Beats on Q3 Earnings & Sales, Revises FY21 View
by Zacks Equity Research
Meritor (MTOR) projects sales at $3.9 billion for fiscal 2021, up from the previous forecast of $3.65-$3.8 billion.
Adient (ADNT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -762.50% and 1.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Oshkosh (OSK) Stock Down Since Q3 Earnings & Revenue Miss
by Zacks Equity Research
Oshkosh (OSK) expects fiscal 2021 adjusted EPS in the band of $6.35-$6.50 compared with the prior view of $6.35-$6.85.
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Q2 Earnings & Sales Miss Mark, 2H'21 View Dull
by Zacks Equity Research
Gentex (GNTX) anticipates lower light vehicle production, and high commodity, freight and labor expenses to weigh on the firm's earnings as well as sales for second-half 2021.